SIRT1 is markedly increased in malignant ovarian tumors (especially, in serous carcinoma) compared to corresponding normal tissues, and up-regulated SIRT1 inactivates p53 by deacetylation [79]. The gene discussed is SIRT1; the disease is serous adenocarcinoma.